1. Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, Rosenthal PJ, Dorsey G, Achan J, Akello C, Kamya MR, Wong JK. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis. 2012 Apr;54(7):1001-9. Epub 2012 Feb 4. PMID: 2230827

2. Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK, Achan J. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr. 2011 Jan;56(1):44-50. PMID: 21099693

3. Charlebois ED, Ruel TD, Gasasira AF, Achan J, Kateera F, Akello C, Cao H, Dorsey G, Rosenthal PJ, Ssewanyana I, Kamya MR, Havlir DV. Short-Term Risk of HIV Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2010 Nov 1;55(3):330-5. PMCID: PMC3025136

4. Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, Ruel T, Kateera F, Meya DN, Havlir D, Rosenthal PJ, Dorsey G. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malaria Journal. 2010 Jun 23;9(1):177. PMCID: PMC2903607

5. Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS. 2010 May 15;24(8):1163-70. PMCID: PMC2880483

6. Bebell LM, Pilcher CD, Dorsey G, Havlir D, Kamya MR, Busch MP, Dunn Williams J, Nugent CT, Bentsen C, Rosenthal PJ, Charlebois ED. 1.Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria.AIDS. 2010 Jul 31;24(12):1945-52. PMID:20543656

7. Ssewanyana I, Baker CAR, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H. The distribution and immune profile of T cells subsets in HIV infected children from Uganda. AIDS Research and Human Retroviruses, 2009 Jan;25(1):65-71). PMCID: PMC2858297.

8. Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong J, Cao H, Havlir D, Charlebois E. Dynamics of T-cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clinical Immunology, Volume 131, Issue 3,June 2009, Pages 410-414. NIHMSID # 268410.

9. Achan J, Gasasira AF, Aweeka F, Havlir D, Rosenthal PJ, Kamya, MR. Prophylaxis and treatment of Malaria in HIV infected populations. Future HIV Ther, 2008 2(5).

10. Ruel T, Achan J, Gasasira AF, Charlebois ED, Mebrahtu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV. HIV RNA suppression among HIV-infected Ugandan Children with Measles. JAIDS 2008:48(2), (1 June):225-227. NIHMSID # 268409.

11. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango, J, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal P, Havlir D, and Dorsey G. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. CID 2008:46 1 April:992-3.

12. Ssewanyana I, Elrefaei M, Dorsey G, Ruel T, Jones NG, Gasasira A, Kamya M, Nakiwala J, Achan J, Charlebois E, Havlir D, Cao H. Profile of T Cell Immune Responses in HIV Infected Children from Uganda. JID 2007:196 (11):1667-70.

13. Kamya, MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. Effects of trimethoprim-sulfamethoxazole prophylaxis and insecticide-treated bednets on the risk of malaria among HIV-infected Ugandan children. AIDS 2007, 21(15):2059-66 2007.

14. Bebell LM, Gasasira AF, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey G. HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. JAIDS 2007, 46(5):624-30.

15. German P, Greenhouse B, Coates C, Dorsey G, Rosenthal P, Charlebois E, Lindegardh N, Havlir D, Aweeka F. Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clin Infect Dis. 2007 Mar 15;44(6):889-91.

16. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol. 2006 Aug;44(8): 3021-4. PMCID: PMC1594619

17. Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis. 2006 Jan 1;193(1):9-15.

18. Parikh S, Liu J, Sijwali P, Gut J, Goldberg DE, Rosenthal PJ. Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin. Antimicrob Agents Chemother. 50:2207-9, 2006. PMCID: PMC1479139

19. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother. 2005 Jul;49(7):2983-5. PMCID: PMC1168637